ENBIOSIS offers more than a single product, it provides a scalable technology platform built on strong scientific and clinical foundations.
Our approach combines clinically supported research, a clear roadmap across disease and wellness areas, and flexible product formats such as powder and bar, all designed for efficient scaling through ongoing R&D.
Our first market-ready product, ENBIOSIS Nutra for Dry Eye, serves as the foundation for a broader and expanding pipeline.
Partnership Oppurtunities
Collaboration models designed to support market expansion, portfolio growth, and long-term value creation.
Distribution Partnerships
We collaborate with regional and global partners to commercialize ENBIOSIS Nutra products in new markets.
Commercial Partnership
We work with strategic partners to co-market, license, and expand ENBIOSIS Nutra products through joint commercial initiatives, private-label opportunities, and shared go-to-market strategies.
Who We Work With?
Pharmaceutical & biotechnology companies
Partner with ENBIOSIS to expand your portfolio with science-backed, microbiome-driven health solutions.
Food & functional nutrition companies
Integrate AI-designed microbiome science into functional products of next-generation supplements.
Ingredient & supplier companies
Apply AI & microbiome intelligence to elevate innovation and unlock new application opportunities.
A Platform Built for Scale
ENBIOSIS products are developed with global scalability in mind, from formulation and manufacturing to regulatory and commercialization pathways.
Our pipeline continues to expand across multiple microbiome-linked indications, creating ongoing opportunities for partners to grow alongside the platform.
Become a Partner
Get in touch with us if you are interested in distributing, collaborating, or exploring strategic opportunities with ENBIOSIS.
Let’s build the future of microbiome-driven health, together.
